Efficacies of BMS 284756 against penicillin-sensitive, penicillin-resistant, and quinolone-resistant pneumococci in experimental meningitis

被引:9
作者
Cottagnoud, P [1 ]
Acosta, F
Cottagnoud, M
Pfister, M
Täuber, MG
机构
[1] Inselspital Bern, Dept Internal Med, Bern, Switzerland
[2] Zieglerspital Bern, Dept Internal Med, Bern, Switzerland
[3] Univ Bern, Inst Infect Dis, Bern, Switzerland
[4] Univ Calif San Francisco, Dept Lab Med & Biopharmaceut Sci, San Francisco, CA 94143 USA
关键词
D O I
10.1128/AAC.46.1.184-187.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
BMS 284756 penetrated well into inflamed meninges (44% +/- 11%) and produced good bactericidal activity (-0.82 +/- 0.22 Delta log(10) CFU/ml (.) h) in the treatment of experimental meningitis in rabbits due to a penicillin-sensitive strain. BMS 284756 monotherapy had a greater potency than the standard regimen of ceftriaxone and vancomycin (-0.49 +/- 0.08 Delta log(10) CFU/ml (.) h) against a penicillin-resistant strain (MIC, 4 mg/liter). Even against a penicillin- and quinolone-resistant strain, BMS 284756 showed good bactericidal activity (-0.52 +/- 0.12 Delta log(10) CFU/ml (.) h). The antibacterial activity of BMS 284756 was confirmed by time-killing assays over 8 h in vitro.
引用
收藏
页码:184 / 187
页数:4
相关论文
共 18 条
[1]   A critical evaluation of vancomycin for treatment of bacterial meningitis [J].
Ahmed, A .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1997, 16 (09) :895-903
[2]   Paracetamol plasma and cerebrospinal fluid pharmacokinetics in children [J].
Anderson, BJ ;
Holford, NHG ;
Woollard, GA ;
Chan, PLS .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (03) :237-243
[3]   THE NONMEM SYSTEM [J].
BEAL, S ;
SHEINER, L .
AMERICAN STATISTICIAN, 1980, 34 (02) :118-119
[4]  
BENETT JE, 1996, J PHARMACOKINET BIOP, V4, P403
[5]   Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro [J].
Cottagnoud, P ;
Acosta, F ;
Cottagnoud, M ;
Neftel, K ;
Täuber, MG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (08) :2179-2181
[6]   EFFECT OF PROBENECID ON CEREBROSPINAL-FLUID CONCENTRATIONS OF PENICILLIN AND CEPHALOSPORIN DERIVATIVES [J].
DACEY, RG ;
SANDE, MA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1974, 6 (04) :437-441
[7]   EVALUATION OF ANTIMICROBIAL REGIMENS FOR TREATMENT OF EXPERIMENTAL PENICILLIN-RESISTANT AND CEPHALOSPORIN-RESISTANT PNEUMOCOCCAL MENINGITIS [J].
FRIEDLAND, IR ;
PARIS, M ;
EHRETT, S ;
HICKEY, S ;
OLSEN, K ;
MCCRACKEN, GH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (08) :1630-1636
[8]   Evaluation of cefepime alone and in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro [J].
Gerber, CM ;
Cottagnoud, M ;
Neftel, K ;
Täuber, MG ;
Cottagnoud, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (01) :63-68
[9]   Grepafloxacin against penicillin-resistant pneumococci in the rabbit meningitis model [J].
Gerber, CM ;
Tovar, L ;
Cottagnoud, M ;
Neftel, KA ;
Täuber, MG ;
Cottagnoud, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (02) :249-253
[10]  
Jacobs Michael R., 1999, American Journal of Medicine, V106, p19S, DOI 10.1016/S0002-9343(98)00351-9